Kiora Pharmaceuticals (7EY.F) Q3 2025 Earnings

8AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.78
-0.68
-0.57
-0.46

Details

Expected EPS
-0.5194772
Actual EPS
-0.4636656
Surprise EPS
0.06
Surprise Percent
+10.74%

Description

Kiora Pharmaceuticals (7EY.F) has reported earnings of -0.4636656 per share for Q3 2025.

0 Comments

Share your thoughts